LYN and cancer: Inference of similarities among tumor samples revealed high level of heterogeneity between lyn 1 and other metastatic lesions (lyn 2/3/4 and BM) (Figure 3B), indicating they may originate from different subclones or cancer foci of the primary tumor, which was consistent previous report (20).